Life ScienceCompany
Sagent Pharmaceuticals M&A Summary
Sagent Pharmaceuticals has acquired 1 company of its own. It has also divested 1 asset.
Sagent Pharmaceuticals’ largest acquisition to date was in 2014, when it acquired Omega Laboratories for $72M. Sagent Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Sagent Pharmaceuticals Ownership
Who owns Sagent Pharmaceuticals?
Sagent Pharmaceuticals is owned by Nichi-Iko Pharmaceutical. It was acquired on July 11, 2016.
Sagent Pharmaceuticals Business Overview
Where is Sagent Pharmaceuticals headquartered?
Sagent Pharmaceuticals is headquartered in Schaumburg, Illinois.
What is Sagent Pharmaceuticals’ revenue?
Sagent Pharmaceuticals disclosed revenue of 318M USD for 2015 and 288M USD for 2014.
How many employees does Sagent Pharmaceuticals have?
Sagent Pharmaceuticals has 440 employees.
What sector is Sagent Pharmaceuticals in?
Sagent Pharmaceuticals is a life science company.
When was Sagent Pharmaceuticals founded?
Sagent Pharmaceuticals was founded in 2006.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
- M&A Advisors 2
Unlimited Searches
